Skip to main navigation Skip to search Skip to main content

Linagliptin as add-on treatment to glimepiride in patients with HNF1A-diabetes (MODY3): a randomised, double-blinded, placebo-controlled, crossover trial

  • A. S. Christensen
  • , S. Haedersdal
  • , J. Stoy
  • , H. Storgaard
  • , U. Kampmann
  • , M. Seghieri
  • , J. J. Holst
  • , T. Hansen
  • , F. K. Knop
  • , T. Vilsboll
Original languageEnglish
Publication dateSept 2020
Publication statusPublished - Sept 2020

Cite this